These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11287454)

  • 1. Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
    Baxter SW; Campbell IG
    J Natl Cancer Inst; 2001 Apr; 93(7):557-9. PubMed ID: 11287454
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
    Hishida A; Hamajima N; Iwata H; Matsuo K; Hirose K; Emi N; Tajima K
    J Natl Cancer Inst; 2002 Dec; 94(23):1807-8. PubMed ID: 12464653
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
    Ameyaw MM; Thornton N; McLeod HL
    J Natl Cancer Inst; 2000 Dec; 92(23):1947. PubMed ID: 11106692
    [No Abstract]   [Full Text] [Related]  

  • 4. Population-based case-control study of HER2 genetic polymorphism and breast cancer risk.
    Chan KY; Cheung AN; Yip SP; Ko HH; Lai TW; Khoo US
    J Natl Cancer Inst; 2002 Oct; 94(20):1581-2. PubMed ID: 12381713
    [No Abstract]   [Full Text] [Related]  

  • 5. Racially restricted contribution of immunoglobulin Fcγ and Fcγ receptor genotypes to humoral immunity to human epidermal growth factor receptor 2 in breast cancer.
    Pandey JP; Namboodiri AM; Kistner-Griffin E; Iwasaki M; Kasuga Y; Hamada GS; Tsugane S
    Clin Exp Immunol; 2013 Mar; 171(3):273-7. PubMed ID: 23379433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of ERBB2 and breast cancer risk: a meta-analysis of 26 studies involving 35,088 subjects.
    Wang H; Liu L; Lang Z; Guo S; Gong H; Guan H; Zhang J; Liu B
    J Surg Oncol; 2013 Nov; 108(6):337-41. PubMed ID: 23900832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case-control studies.
    Lu S; Wang Z; Liu H; Hao X
    Breast Cancer Res Treat; 2010 Dec; 124(3):771-8. PubMed ID: 20401632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
    Siddig A; Mohamed AO; Kamal H; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
    Ann N Y Acad Sci; 2008 Sep; 1138():84-94. PubMed ID: 18837888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites.
    Millikan R; Eaton A; Worley K; Biscocho L; Hodgson E; Huang WY; Geradts J; Iacocca M; Cowan D; Conway K; Dressler L
    Breast Cancer Res Treat; 2003 Jun; 79(3):355-64. PubMed ID: 12846420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of the beta chain of the high-affinity immunoglobulin E receptor (Fcepsilon RI-beta) in South African black and white asthmatic and nonasthmatic individuals.
    Green SL; Gaillard MC; Song E; Dewar JB; Halkas A
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1487-92. PubMed ID: 9817697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
    Xie D; Shu XO; Deng Z; Wen WQ; Creek KE; Dai Q; Gao YT; Jin F; Zheng W
    J Natl Cancer Inst; 2000 Mar; 92(5):412-7. PubMed ID: 10699071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: CYP17 promoter polymorphism and breast cancer in Australian women under age forty years.
    Jernström H; Vesprini D; Bradlow HL; Narod SA
    J Natl Cancer Inst; 2001 Apr; 93(7):554-5. PubMed ID: 11287451
    [No Abstract]   [Full Text] [Related]  

  • 13. Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites.
    Millikan RC; Player J; de Cotret AR; Moorman P; Pittman G; Vannappagari V; Tse CK; Keku T
    Breast Cancer Res; 2004; 6(4):R264-74. PubMed ID: 15217492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does race modify the association between CYP1B1 Val432Leu polymorphism and breast cancer risk? A critical appraisal of a recent meta-analysis.
    Economopoulos KP; Sergentanis TN
    Breast Cancer Res Treat; 2010 Nov; 124(1):293-4. PubMed ID: 20686834
    [No Abstract]   [Full Text] [Related]  

  • 15. A case-control study of the HER2 Ile655Val polymorphism and risk of breast cancer in Taiwan.
    Lee SC; Hou MF; Hsieh PC; Wu SH; Hou LA; Ma H; Tsai SM; Tsai LY
    Clin Biochem; 2008 Feb; 41(3):121-5. PubMed ID: 18062925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
    Hauptmann M; Sigurdson AJ; Chatterjee N; Rutter JL; Hill DA; Doody MM; Struewing JP
    J Natl Cancer Inst; 2003 Aug; 95(16):1251-2. PubMed ID: 12928354
    [No Abstract]   [Full Text] [Related]  

  • 17. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk.
    Moysich KB; Shields PG; Freudenheim JL; Schisterman EF; Vena JE; Kostyniak P; Greizerstein H; Marshall JR; Graham S; Ambrosone CB
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):41-4. PubMed ID: 9950238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of HER2 genotypes as molecular markers on breast cancer outcome.
    Mutluhan H; Akbas E; Erdogan NE; Soylemez F; Senli MS; Polat A; Helvaci I; Seyrek E
    DNA Cell Biol; 2008 Oct; 27(10):575-9. PubMed ID: 18721072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trinucleotide repeat polymorphism within the human antithrombin gene (AT3): allele frequency data for three population groups.
    Waye JS; Eng B; Ni HY; Blajchman MA; Carmody G
    Mol Cell Probes; 1994 Apr; 8(2):149-54. PubMed ID: 7935513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility: meta-analysis of 22 studies involving 19,341 subjects.
    Ma Y; Yang J; Zhang P; Liu Z; Yang Z; Qin H
    Breast Cancer Res Treat; 2011 Jan; 125(1):237-41. PubMed ID: 20524057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.